Parexel International Corp (PRXL)

68.50
1.82 2.59
NASDAQ : Health Care
Prev Close 70.32
Open 70.02
Day Low/High 68.11 / 70.28
52 Wk Low/High 56.00 / 76.17
Volume 296.82K
Avg Volume 394.80K
Exchange NASDAQ
Shares Outstanding 53.18M
Market Cap 3.74B
EPS 2.90
P/E Ratio 24.57
Div & Yield N.A. (N.A)

Latest News

PAREXEL International To Present At Wells Fargo Healthcare Conference

PAREXEL International To Present At Wells Fargo Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today it will be presenting at the Wells Fargo Healthcare Conference on Wednesday September 7, 2016 in Boston.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Violations Of Federal Securities Laws By Certain Officers And Directors Of PAREXEL International Corporation

Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ:PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its...

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against PAREXEL International Corporation - PRXL

Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of PAREXEL International Corporation (NASDAQ:PRXL) resulting from allegations that...

Ubavka DeNoble, MD, Corporate Vice President, PAREXEL, Named By PharmaVOICE As One Of The 100 Most Inspiring People In The Life Sciences Industry. (Photo: Business Wire)

Ubavka DeNoble, MD, Corporate Vice President, PAREXEL, Named By PharmaVOICE As One Of The 100 Most Inspiring People In The Life Sciences Industry. (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that PharmaVOICE magazine selected Ubavka DeNoble, MD, Corporate Vice President, as one of the 100...

PAREXEL International Reports Fourth Quarter And Fiscal Year 2016 Results

PAREXEL International Reports Fourth Quarter And Fiscal Year 2016 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the fourth quarter and Fiscal Year 2016, which ended on June 30, 2016.

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

Joshua Schultz, Senior Vice President, Worldwide Head Of PAREXEL Access (Photo: Business Wire)

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of four company executives to its senior-most leadership team, the Business Review...

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Analysts' Actions -- Groupon, Humana, Monster, Merck and More

Here are Monday's top research calls, including upgrades for Groupon and Humana, and downgrades for Monster Beverage and Merck.

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for Fourth Quarter and Fiscal Year 2016 on Wednesday, August 3, 2016 after the close of the stock market.

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

The sharp declines seen across the healthcare sector could present buying opportunities in companies such as Aetna, HCA, Icon and Paraxel.

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2016

PAREXEL Experts To Discuss Key Drug Development Insights At DIA 2016

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts will discuss key issues facing the industry at the 52 nd Annual Drug...

PAREXEL Invites Public To Listen To Live Webcast Of Investor Day Presentations On June 30

PAREXEL Invites Public To Listen To Live Webcast Of Investor Day Presentations On June 30

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor Day presentations on Thursday, June 30, 2016, from...

PAREXEL Announces Master Services Agreement With Pfizer

PAREXEL Announces Master Services Agreement With Pfizer

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has signed a services agreement with Pfizer Inc.

PAREXEL Named Company Of The Year For The Pharmaceuticals Industry With A Gold Stevie From The American Business Awards

PAREXEL Named Company Of The Year For The Pharmaceuticals Industry With A Gold Stevie From The American Business Awards

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, has been named Company of the Year - Pharmaceuticals in the 14 th Annual American Business Awards SM.

PAREXEL International To Present At Goldman Sachs Global Healthcare Conference And Jefferies Healthcare Conference

PAREXEL International To Present At Goldman Sachs Global Healthcare Conference And Jefferies Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that executives will be making a presentation on PAREXEL and discussing business developments and financial outlook at two investor conferences in June.

PAREXEL International To Present At UBS Healthcare Conference

PAREXEL International To Present At UBS Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Tuesday, May 24, 2016, in New York City.

PAREXEL International Reports Third Quarter Fiscal Year 2016 Results

PAREXEL International Reports Third Quarter Fiscal Year 2016 Results

PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2016, which ended on March 31, 2016.

3 Stocks Pushing The Health Services Industry Lower

3 Stocks Pushing The Health Services Industry Lower

TheStreet highlights 3 stocks pushing the health services industry lower today.

PAREXEL International To Present At Deutsche Bank Healthcare Conference

PAREXEL International To Present At Deutsche Bank Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will present at the Deutsche Bank 41st Annual Health Care Conference in Boston.

PAREXEL And EMC Form Alliance To Provide Cloud-Based Document And Regulatory Information Management Services

PAREXEL And EMC Form Alliance To Provide Cloud-Based Document And Regulatory Information Management Services

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, and EMC Corporation (NYSE: EMC) today announced they have entered into an alliance to offer an end-to-end...

14 Cheap Stocks to Buy Now From Goldman Sachs

14 Cheap Stocks to Buy Now From Goldman Sachs

These 14 inexpensive stocks are expected to have strong top-line growth in the next two years, says Goldman Sachs.

Insider Trading Alert - O, PRXL And CNBKA Traded By Insiders

Insider Trading Alert - O, PRXL And CNBKA Traded By Insiders

Stocks with insider trader activity include O, PRXL and CNBKA

PAREXEL International Announces Date Of Third Quarter Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Announces Date Of Third Quarter Fiscal Year 2016 Earnings Release And Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2016 on Wednesday, April 27 th, 2016 after the close of the stock market.

PAREXEL Named To The 2016 Forbes America's Best Employers List

PAREXEL Named To The 2016 Forbes America's Best Employers List

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that Forbes named the Company to the magazine's America's "Best Employers" list for 2016.

Insider Trading Alert - TREX, PRXL And ARE Traded By Insiders

Insider Trading Alert - TREX, PRXL And ARE Traded By Insiders

Stocks with insider trader activity include TREX, PRXL and ARE

PAREXEL International To Present At Barclay's Global Healthcare Conference

PAREXEL International To Present At Barclay's Global Healthcare Conference

PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Barclay's Global Healthcare Conference on Thursday, March 17, 2016, in Miami.